Cerenome is trading 4.8% up at $1.97 in pre-market, with healthcare-sector strength the clearest available context.
- Compared with the October 15 close of $1.88.
- No new company-specific announcement explaining the move was found; available evidence points to a sector-driven move, not a confirmed catalyst. Recent Cerenome announcements predate this session.
- Defensive rotation supported healthcare stocks during the October 15 rebound, and the sector remains higher in pre-market.